Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2018
Thyroid Nodule DNA Methylation Signatures: An Important Diagnostic AnnotationElliot J Mitmaker, Roger Tabah, Jacques How
Cancers|November 28, 2013
The evolution of biomarkers in thyroid cancer-from mass screening to a personalized biosignatureRaymon H Grogan, Elliot J Mitmaker, Orlo H Clark
Cancer Control : Journal of the Moffitt Cancer Center|April 1, 2011
Changing paradigms in the treatment of malignant pheochromocytomaRaymon H Grogan, Elliot J Mitmaker, Quan-Yang Duh
The Journal of Clinical Endocrinology and Metabolism|April 2, 2014
Cost-effectiveness of molecular testing for thyroid nodules with atypia of undetermined significance cytologyLawrence Lee, Jacques How, Roger J Tabah, et al.
Thyroid : Official Journal of the American Thyroid Association|December 31, 2015
Cost-Effectiveness of Diagnostic Lobectomy Versus Observation for Thyroid Nodules >4 cmLawrence Lee, Elliot J Mitmaker, John A Chabot, et al.
Plos One|February 23, 2016
Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer CellsIdit Dotan, Philip J R Roche, Miltiadis Paliouras, et al.
Plos One|June 17, 2016
Correction: Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer CellsIdit Dotan, Philip J R Roche, Michael Tamilia, et al.
Surgery|October 6, 2015
Selective strategy for intensive monitoring after pheochromocytoma resectionCassandre E Bénay, Mehdi Tahiri, Lawrence Lee, et al.
World Journal of Surgery|November 8, 2017
Measuring Decision-Making During Thyroidectomy: Validity Evidence for a Web-Based Assessment ToolAmin Madani, Jordan Gornitsky, Yusuke Watanabe, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|March 30, 2017
Prostate-specific membrane antigen-directed nanoparticle targeting for extreme nearfield ablation of prostate cancer cellsSeung S Lee, Philip Jr Roche, Paresa N Giannopoulos, et al.
Pageof 2